Company: CRVO
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001437749-25-013543
Chunk: 13

Company: CervoMed Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 13
---
 by the Listing Rules of the Nasdaq Capital Market, the Board has adopted certain governance standards, including its standard of independence.

Corporate Governance Guidelines

Our Board has adopted Corporate Governance Guidelines, a copy of which can be found on the Investor Relations—Corporate Governance section of our corporate website at www.cervomed.com. Among the topics addressed in our Corporate Governance Guidelines are:

| ● | Board size, composition and qualifications;          | ● | Retirement and resignation policy;                          |
| ● | Selection of directors;                              | ● | Board compensation;                                         |
| ● | Board leadership;                                    | ● | Loans to directors and executive officers;                  |
| ● | Board committees;                                    | ● | Chief Executive Officer evaluation;                         |
| ● | Board and committee meetings;                        | ● | Board and committee evaluations;                            |
| ● | Executive sessions of outside directors;             | ● | Director continuing education;                              |
| ● | Meeting attendance by directors and non-directors;   | ● | Succession planning;                                        |
| ● | Appropriate information and access;                  | ● | Related person transactions;                                |
| ● | Ability to retain advisors;                          | ● | Communication with directors;                               |
| ● | Conflicts of interest and director independence;     | ● | Director attendance at annual meetings of stockholders; and |
| ● | Board interaction with corporate constituencies;     | ● | Change of principal occupation and board memberships.       |
| ● | Stock ownership by directors and executive officers; |   |                                                             |
| ● | Retirement and term limits;                          |   |                                                             |

Directors & Director Independence

Nasdaq rules generally require that independent directors must comprise a majority of the listed company’s board of directors. Based upon information requested from and provided by each director concerning his or her background, employment and affiliations, including family relationships, the Board has determined that five of our eight current directors — Joshua S. Boger, Ph.D., Jane H. Hollingsworth, J.D., Jeff Poulton, Marwan Sabbagh, M.D., and Frank Zavrl — are “independent directors” as that term is defined under the applicable rules and regulations of the SEC and under the Listing Rules of the Nasdaq Capital Market.

Certain Family Relationships

Dr. Alam and Dr. Grégoire are married and therefore "immediate family members" as defined in Item 404 of Regulation S-K. Other than their relationship, there are no family relationships among any of our directors or executive officers